HDA study gauges specialty drug market
ARLINGTON, Va. — In the specialty pharmaceutical arena, products in the autoimmune/immune and ophthalmology categories stand to grow in importance over the next 12 months, followed by oncology, central nervous system and inflammatory drugs, according to the HDA Research Foundation. Oncology still represents for the biggest share of specialty drug distributor sales volume, based on
